Record Information
Version1.0
Creation Date2019-07-14 16:35:17 UTC
Last Updated2019-10-01 21:40:54 UTC
CypComp IDCC01855
Compound Information
NameMexiletine
Structure ImageVlpiatfuuwwmkc snvbaglbsa n
InChIKeyVLPIATFUUWWMKC-SNVBAGLBSA-N
PubChem ID180621
CypCompound Information
SetCypBoM Training Set
Bonds of Metabolism (BoMs)
CYP1A2CYP2A6CYP2B6CYP2C8CYP2C9CYP2C19CYP2D6CYP2E1CYP3A4
  • <6,H;Hydroxylation;R1>
  • <8,H;Hydroxylation;R2>
  • <10,H;Hydroxylation;R3>
  • <13,H;Hydroxylation;R4>
  • Not Available
  • <13,H;Hydroxylation;R1>
  • Not Available
  • Not Available
  • Not Available
  • <5,H;Hydroxylation;R1>
  • <7,H;Hydroxylation;R2>
  • <6,H;Hydroxylation;R3>
  • <8,H;Hydroxylation;R4>
  • <10,H;Hydroxylation;R5>
  • <13,H;Hydroxylation;R6>
  • Not Available
  • <13,H;Hydroxylation;R1>
References
  1. Labbe L, Abolfathi Z, Lessard E, Pakdel H, Beaune P, Turgeon J: Role of specific cytochrome P450 enzymes in the N-oxidation of the antiarrhythmic agent mexiletine. Xenobiotica. 2003 Jan;33(1):13-25. doi: 10.1080/0049825021000017948. [PubMed:12519691 ]
  2. Nakajima M, Kobayashi K, Shimada N, Tokudome S, Yamamoto T, Kuroiwa Y: Involvement of CYP1A2 in mexiletine metabolism. Br J Clin Pharmacol. 1998 Jul;46(1):55-62. doi: 10.1046/j.1365-2125.1998.00048.x. [PubMed:9690950 ]
Download FileCC01855.sdf